CURIS, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
CURIS, INC. (CRIS) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $0.00 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-08-14
- CURIS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2026-03-31 was $0.00.
- CURIS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2025-03-31 was $0.00.
- CURIS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- CURIS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2023-03-31 was $0.67.
- CURIS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $0.00.
- CURIS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- CURIS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $13.40.
- CURIS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | $0.00 10-K · filed 2026-03-24 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-05 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-06 | |||
| 2024-12-31 | $0.00 10-K · filed 2025-03-31 | |||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-01 | |||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-07 | |||
| 2023-12-31 | $13.40 10-K · filed 2024-02-08 | |||
| 2023-09-30 | $13.40 10-Q · filed 2023-11-02 | |||
| 2023-06-30 | $0.67 10-Q · filed 2023-08-03 | |||
| 2023-03-31 | $0.67 10-Q · filed 2023-05-04 | |||
| 2022-12-31 | $0.00 10-K · filed 2023-03-13 | |||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-09 | |||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 | |||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-05 | |||
| 2021-12-31 | $1.67 10-K · filed 2022-02-24 | |||
| 2021-09-30 | $1.74 10-Q · filed 2021-11-09 | |||
| 2021-06-30 | $1.75 10-Q · filed 2021-08-03 | |||
| 2021-03-31 | $2.49 10-Q · filed 2021-05-12 | |||
| 2020-12-31 | $1.86 10-K · filed 2021-03-16 | |||
| 2020-09-30 | $1.17 10-Q · filed 2020-11-10 | |||
| 2020-06-30 | $1.17 10-Q · filed 2020-08-04 | |||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-12 | |||
| 2019-12-31 | $0.00 10-K · filed 2020-03-19 | |||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-05 | |||
| 2019-06-30 | $0.00 10-Q · filed 2019-08-09 | |||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-14 | |||
| 2018-12-31 | $0.00 10-K · filed 2019-03-26 | |||
| 2018-09-30 | $0.00 10-Q · filed 2018-11-01 | |||
| 2018-06-30 | $0.00 10-Q · filed 2018-08-02 | |||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-03 | |||
| 2017-12-31 | $1.36 10-K · filed 2018-03-08 | |||
| 2017-09-30 | $1.36 10-Q · filed 2017-11-07 | |||
| 2017-06-30 | $1.38 10-Q · filed 2017-08-03 | |||
| 2017-03-31 | $1.42 10-Q · filed 2017-05-04 | |||
| 2016-12-31 | $1.48 10-K · filed 2017-03-09 | |||
| 2015-12-31 | $1.63 10-K · filed 2016-02-29 | |||
| 2014-12-31 | $1.86 10-K · filed 2015-02-24 | |||
| 2013-12-31 | $2.12 10-K · filed 2014-03-13 | |||
| 2012-12-31 | $1.69 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |